FOxTROT: Randomized phase II study of neoadjuvant chemotherapy with or without an anti-EGFR monoclonal antibody for locally advanced, operable colon cancer. Background: Profiling protein signaling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback